Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amphotericin B and Fluconazole for AIDS-Associated Cryptococcal Meningitis
NCT00145249Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- May 2005
- Primary completion
- Apr 2008
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
Phase 2, randomised, open-label trial of fluconazole in cryptococcal meningitis, sponsored by National Institute of Allergy and Infectious Diseases. Started May 2005; status: completed.
02
Drugs
fluconazole
03
Conditions
cryptococcal meningitis
Beyond the preview
Go deeper on NCT00145249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00145249.